Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • Investor Portal
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • Investor Portal/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • Investor Portal/

News From the Bluestem Team

May 08, 2019

Transcript of OCTANe Q&A with TearClear CEO Kevin Hershfield

May 08, 2019/ Michele Kleinwolterink

Visit TearClear’s website to see the transcript of a conversation between Kevin Hershfield and OCTANe to learn how the company is on a path to solve a critical unmet need in ophthalmology. Click here to view a PDF version.

-Shared by Tyler Stowater, board member of TearClear Corp.

May 08, 2019/ Michele Kleinwolterink/

Michele Kleinwolterink

  • TearClear Appoints Chief Scientific ...
  • eyeBrain in the News

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.